Navigation Links
ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
Date:9/12/2013

DENVER, Sept. 12, 2013 /PRNewswire/ -- ViiV Healthcare today announced initial results from the Phase IIIb/IV FLAMINGO (ING114915) study. This open-label study, for the first time, compared once-daily regimens containing 50mg dolutegravir with once-daily regimens containing a protease inhibitor (PI) (800mg darunavir boosted with 100mg ritonavir) in treatment-naive adults with HIV-1. Both treatment arms were administered with investigator-selected dual NRTIs. Non-inferiority was demonstrated at the 48-week time point between the dolutegravir and darunavir-based regimens. A subsequent, pre-specified testing procedure demonstrated statistical superiority in the dolutegravir treatment arm.

At 48 weeks, a significantly greater proportion of the patients treated with the dolutegravir regimen (90%) were virologically suppressed (HIV-1 RNA <50 copies/mL, the primary endpoint of the study per FDA snapshot) compared to those treated with the darunavir regimen (83%, adjusted treatment difference [95% CI] 7.1% (0.9%, 13.2%); P=0.025; N=242 in each arm). Comparing the dolutegravir and darunavir arms, rates of virologic non-response were 6% versus 7%, rates of treatment withdrawal due to adverse events were 1% versus 4%, and rates of treatment withdrawal for other reasons (such as protocol deviation, lost to follow-up or consent withdrawn) were 2% versus 5%. There were no treatment-emergent primary viral mutations leading to treatment resistance in either study arm. These data were presented at the 53rd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colorado.1 

"These new clinical data are an important addition to our scientific understanding of dolutegravir," said Dr John Pottage, Chief Medical Officer, ViiV Healthcare. "This is the first study in our clinical programme to compare dolutegravir to a boosted protease
'/>"/>

SOURCE ViiV Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
7. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
8. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
11. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Oct. 2, 2014   West Pharmaceutical Services, Inc. ... in innovative solutions for injectable drug administration, announced today ... include a new site in Waterford, Ireland ... for insulin injector cartridges and other high-value packaging components, ... biotech customers. Once operational, this new site could bring ...
(Date:10/1/2014)... DUBLIN, Ohio , Oct. 1, 2014 ... to shareholders is now available. Interested parties can ... and how Cardinal Health is supporting the ... at http://cardinalhealth.com/annualreport . Photo- ... addition to summary financials and the chief ...
(Date:10/1/2014)... 1, 2014  ResMed (NYSE: RMD ), a ... company to design complete sleep apnea solutions specifically for women, ... importance of a good night,s sleep. The ... that feeling tired is just part of living a busy ... a critical pillar of health, essential to not only living ...
Breaking Medicine Technology:West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 2West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 3West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 4West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 5Cardinal Health 2014 Digital Report to Shareholders Now Available 2ResMed Launches Initiative to Help Women Get Better Sleep 2ResMed Launches Initiative to Help Women Get Better Sleep 3
(Date:10/2/2014)... Originally considered alternative food only ... increasingly popular with consumers. This has fuelled demand ... industry in Australia. According to IBISWorld industry ... has surged over the past five years, contributing ... level.” Over the five years through 2014-15, industry ...
(Date:10/2/2014)... Maureen Salamon HealthDay ... -- Middle-aged women with a neurotic personality style and ... Alzheimer,s disease, new research suggests. Tracking 800 women ... who were most anxious, jealous and moody -- which ... had double the risk of developing Alzheimer,s compared to ...
(Date:10/2/2014)... (HealthDay News) -- Children with autism are more sedentary ... of being more active, a small study suggests. ... children, some with autism and some without. Children with ... physical activity and 70 more minutes each day sitting ... autism scored lower on strength, but had similar body-mass ...
(Date:10/2/2014)... Amy Norton HealthDay Reporter WEDNESDAY, ... smelling the roses -- literally -- may face an increased risk ... In a study of over 3,000 older Americans, researchers found those ... peppermint were more than three times as likely to die in ... smell. In fact, anosmia -- the inability to distinguish odors ...
(Date:10/2/2014)... medical discovery by scientists at The University of Nottingham ... type of painkiller. , A drug resulting from the ... , would offer new hope to sufferers of chronic ... few effective painkillers are currently available. , The work, ... of Life Sciences, in collaboration with David Bates, Professor ...
Breaking Medicine News(10 mins):Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 3Health News:Medical discovery first step on path to new painkillers 2
... PhD, president of The J. David Gladstone Institutes, ... The award recognizes his leadership as Gladstone,s founding ... one of the world,s foremost independent research institutions, ... impact on disease prevention. Mahley will be ...
... ... regarding 2010 Shanghai, China Expo -- attracting attention from all walks of life. , ... Beijing (PRWEB) February 10, 2010 -- ... biggest World Expo in the history of world expositions. , , ,This special tour has ...
... women don,t know it is leading killer, survey finds , ... almost half of all American women still don,t know that ... new research finds. , Even more concerning, only slightly more ... they were having heart attack symptoms, according to the latest ...
... with Inflammatory Bowel Disease (IBD) are known to be at high ... of their disease but now new research by scientists at The ... to hospital during flare-ups are also at risk. The two ... affect about one in every 250 people in the UK. The ...
... ... to learn how to differentiate from competition and manage risk. , ... Lafayette, CO (PRWEB) February 10, 2010 -- Auto dealers will be able ... lead-generation, HR best practices and OSHA regulations at the Orlando NADA Convention and Expo 2010., , ...
... Poll Finds Voters Prefer Tobacco Tax to Other Tax Increases, Budget Cuts ... Utah ,s cigarette tax by $1 per pack would bring ... the state,s budget shortfall, while also reducing smoking and saving lives, according ... organizations.  In Utah, health advocates are calling on state leaders to increase ...
Cached Medicine News:Health News:Gladstone's Robert Mahley to receive Research!America advocacy award 2Health News:Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010 2Health News:Women's Heart Disease Awareness Still Lacking 2Health News:Women's Heart Disease Awareness Still Lacking 3Health News:Bowel disease link to blood clots 2Health News:Bowel disease link to blood clots 3Health News:KPA and TK Carsites offer HR, OSHA and Internet Marketing Workshops at the NADA Convention and Expo 2010 2Health News:New Report: $1 Cigarette Tax Increase Would Raise $43.3 Million for Utah and Cut Youth Smoking 2Health News:New Report: $1 Cigarette Tax Increase Would Raise $43.3 Million for Utah and Cut Youth Smoking 3
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband....
It is a fiberoptic based intracranial monitoring systems for continuous monitoring of pressure....
... The Polaris system delivers the most ... effective and easy to use, this ... of precision measurement with unprecedented tracking ... active and passive tools, the Polaris ...
Penfield Dissector #2...
Medicine Products: